These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1463339)

  • 41. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
    Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
    Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study.
    Bukowski RM; Fleming TR; Macdonald JS; Oishi N; Taylor SA; Baker LH
    Cancer; 1993 Jan; 71(2):322-5. PubMed ID: 8422624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study.
    Bukowski RM; Balcerzak SP; O'Bryan RM; Bonnet JD; Chen TT
    Cancer; 1983 Nov; 52(9):1577-82. PubMed ID: 6225508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
    Oster MW; Gray R; Panasci L; Perry MC
    Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.
    Topham C; Glees J; Rawson NS; Woods EM; Coombes RC
    Br J Cancer; 1991 Jul; 64(1):179-81. PubMed ID: 1906726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy for advanced gastric carcinoma.
    JAMA; 1986 Jan; 255(3):321-3. PubMed ID: 3753616
    [No Abstract]   [Full Text] [Related]  

  • 47. Chemotherapy for pancreatic cancer.
    Arbuck SG
    Baillieres Clin Gastroenterol; 1990 Dec; 4(4):953-68. PubMed ID: 2078794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth-inhibitory effect of combination chemotherapy for human pancreatic cancer cell lines.
    Matsuno S; Hisano H; Kobari M; Akaishi S
    Cancer; 1990 Dec; 66(11):2369-74. PubMed ID: 2123126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experience.
    Treat J; Falchuk SC; Woolley PV; Ahlgren JD; Neefe JR; Smith FP; Macdonald JS; Schein PS
    Am J Clin Oncol; 1989 Apr; 12(2):162-8. PubMed ID: 2523188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intermittent intensive combination chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (cyclic PAC chemotherapy) for ovarian cancer.
    Inoue M; Nakanishi K; Ueda G; Tanizawa O
    Am J Clin Oncol; 1992 Feb; 15(1):1-6. PubMed ID: 1550076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective intra-arterial chemotherapy for acinar cell carcinoma of the pancreas.
    Ukei T; Okagawa K; Uemura Y; Miyauchi K; Kaneko T; Mizunoya S; Monden M
    Dig Surg; 1999; 16(1):76-9. PubMed ID: 9949272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy of carcinoma of renal pelvis: preliminary report.
    Trindade A; Samuels ML; Logothetis CJ
    Urology; 1981 Jul; 18(1):54-9. PubMed ID: 6894814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future management.
    Smith FP; Stablein D; Korsmeyer S; Neefe J; Chun BK; Woolley PV; Schein PS
    J Clin Oncol; 1983 Jul; 1(7):413-5. PubMed ID: 6689426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy in advanced urinary bladder cancer.
    Edsmyr F; Andersson L; Esposti PL
    Urology; 1984 Mar; 23(3 Suppl):51-3. PubMed ID: 6199883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
    Rivera E; Ajani JA
    Am J Clin Oncol; 1998 Feb; 21(1):36-8. PubMed ID: 9499254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [TS-1: S-1 based chemotherapy for far-advanced or relapsed pancreatic cancer].
    Hayashi K; Uchida K; Hatori T; Takasaki K
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():194-7. PubMed ID: 16457248
    [No Abstract]   [Full Text] [Related]  

  • 57. Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).
    Smith PH; Child JA; Mulder JH; Van Oosterom AT; Martinez-Pineiro JA; Richards B; Stoter G; Dalesio O; De Pauw M; Sylvester R
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S25-31. PubMed ID: 6416699
    [No Abstract]   [Full Text] [Related]  

  • 58. The role of chemotherapy in the management of gastric and pancreatic carcinomas.
    Schein PS
    Semin Oncol; 1985 Dec; 12(4 Suppl 6):49-60. PubMed ID: 3936182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiation and concurrent chemotherapy for the treatment of Lewis lung tumor and B16 melanoma tumor in C57/BL mice.
    Pedersen JE; Barron G
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1479-82. PubMed ID: 6432748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-Fluorouracil + cisplatin + mitomycin C is a relatively most effective combination against xenograft lines of human colorectal cancer.
    Kawabata K; Nio Y; Imamura M
    Anticancer Drugs; 1997 Sep; 8(8):790-6. PubMed ID: 9396624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.